Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC)
European Research Infrastructure Consortium (ERIC)
ENTRY INTO FORCE
On November 30, 2013, the BBMRI-ERIC Statutes were published in the Official Journal of the European Union and entered into force three days after publication on 3 December 2013. As from this date, the Biobanking and Biomolecular resources Research Infrastructure (BBMRI) was officially awarded the Community legal framework for a European Research Infrastructure Consortium (ERIC) and is henceforth to be called BBMRI-ERIC.
PHILOSOPHY, NATURE AND PURPOSE OF BUSINESS
BBMRI-ERIC is designed to facilitate the joint establishment and operation of research infrastructures of European interest. The ERIC status allows pulling together biobanks and biomolecular resources into a pan-European facility and providing access to collections of partner biobanks and biomolecular resources, their expertise and services on a non-economic basis. BBMRI-ERIC is established for an unlimited period of time.
Members of BBMRI-ERIC
PROCUREMENT AND TAX EXEMPTION
BBMRI-ERIC benefits from tax exemption as outlined in Article 6 of the BBMRI-ERIC Statutes.
Kingdom of Belgium, Republic of Bulgaria, Czech Republic, Federal Republic of Germany, Republic of Estonia, Hellenic Republic, Italian Republic, Republic of Latvia, Republic of Malta, Kingdom of the Netherlands, Kingdom of Norway, Republic of Austria, Republic of Poland, Republic of Finland, Kingdom of Sweden, United Kingdom of Great Britain and Northern Ireland
Republic of Cyprus, Republic of Lithuania, Swiss Confederation, Republic of Turkey, International Agency for Research on Cancer (IARC/WHO)
The activities of BBMRI-ERIC shall be politically neutral and guided by the following values: pan-European in scope, combined with scientific excellence, transparency, openness, responsiveness, ethical awareness, legal compliance and human values.